Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2020224707', 'doi': 'https://doi.org/10.1158/1078-0432.ccr-04-0993', 'title': 'Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines', 'display_name': 'Enhanced Sensitivity to the HER1/Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Erlotinib Hydrochloride in Chemotherapy-Resistant Tumor Cell Lines', 'publication_year': 2005, 'publication_date': '2005-02-15', 'ids': {'openalex': 'https://openalex.org/W2020224707', 'doi': 'https://doi.org/10.1158/1078-0432.ccr-04-0993', 'mag': '2020224707', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15746062'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1078-0432.ccr-04-0993', 'pdf_url': 'https://aacrjournals.org/clincancerres/article-pdf/11/4/1572/1961845/1572-1578.pdf', 'source': {'id': 'https://openalex.org/S183149254', 'display_name': 'Clinical Cancer Research', 'issn_l': '1078-0432', 'issn': ['1078-0432', '1557-3265'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://aacrjournals.org/clincancerres/article-pdf/11/4/1572/1961845/1572-1578.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5030533961', 'display_name': 'Qun Dai', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}, {'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Qun Dai', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I1335289525', 'https://openalex.org/I129975664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5064616037', 'display_name': 'Yi‐He Ling', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}, {'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yi-He Ling', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I1335289525', 'https://openalex.org/I129975664']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048925071', 'display_name': 'Marie Lia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}, {'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Marie Lia', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I129975664', 'https://openalex.org/I1335289525']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5102082465', 'display_name': 'Yi-Yu Zou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}, {'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Yi-Yu Zou', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I129975664', 'https://openalex.org/I1335289525']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071551404', 'display_name': 'Glenn Kroog', 'orcid': 'https://orcid.org/0009-0000-2897-9810'}, 'institutions': [{'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}, {'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Glenn Kroog', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I129975664', 'https://openalex.org/I1335289525']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013449798', 'display_name': 'Kenneth K. Iwata', 'orcid': 'https://orcid.org/0009-0003-5842-2863'}, 'institutions': [{'id': 'https://openalex.org/I4210129988', 'display_name': 'Arrien Pharmaceuticals (United States)', 'ror': 'https://ror.org/02x59h163', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210129988']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kenneth K. Iwata', 'raw_affiliation_strings': ['2OSI Pharmaceuticals, Boulder, Colorado'], 'affiliations': [{'raw_affiliation_string': '2OSI Pharmaceuticals, Boulder, Colorado', 'institution_ids': ['https://openalex.org/I4210129988']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5063025231', 'display_name': 'Román Pérez-Soler', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I129975664', 'display_name': 'Albert Einstein College of Medicine', 'ror': 'https://ror.org/05cf8a891', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I129975664', 'https://openalex.org/I4210112371']}, {'id': 'https://openalex.org/I1335289525', 'display_name': 'Montefiore Medical Center', 'ror': 'https://ror.org/044ntvm43', 'country_code': 'US', 'type': 'healthcare', 'lineage': ['https://openalex.org/I1335289525']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Roman Perez-Soler', 'raw_affiliation_strings': ['1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and'], 'affiliations': [{'raw_affiliation_string': '1Department of Oncology, Montefiore Medical Center/Albert Einstein College of Medicine, Bronx, New York, and', 'institution_ids': ['https://openalex.org/I129975664', 'https://openalex.org/I1335289525']}]}], 'countries_distinct_count': 1, 'institutions_distinct_count': 3, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 6.143, 'has_fulltext': True, 'fulltext_origin': 'pdf', 'cited_by_count': 89, 'citation_normalized_percentile': {'value': 0.968455, 'is_in_top_1_percent': False, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '11', 'issue': '4', 'first_page': '1572', 'last_page': '1578'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10417', 'display_name': 'Advancements in Lung Cancer Research', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10755', 'display_name': 'HER2 Signaling in Breast Cancer Treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11067', 'display_name': 'Advancements in Colorectal Cancer Research', 'score': 0.9993, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/erlotinib-hydrochloride', 'display_name': 'Erlotinib Hydrochloride', 'score': 0.5817264}, {'id': 'https://openalex.org/keywords/receptor-tyrosine-kinase', 'display_name': 'Receptor Tyrosine Kinase', 'score': 0.553786}, {'id': 'https://openalex.org/keywords/egfr', 'display_name': 'EGFR', 'score': 0.51757}, {'id': 'https://openalex.org/keywords/egfr-inhibitors', 'display_name': 'EGFR Inhibitors', 'score': 0.50139}], 'concepts': [{'id': 'https://openalex.org/C2778087573', 'wikidata': 'https://www.wikidata.org/wiki/Q418369', 'display_name': 'Erlotinib', 'level': 4, 'score': 0.9164546}, {'id': 'https://openalex.org/C2778820342', 'wikidata': 'https://www.wikidata.org/wiki/Q906415', 'display_name': 'Tyrosine-kinase inhibitor', 'level': 3, 'score': 0.63610256}, {'id': 'https://openalex.org/C2779438470', 'wikidata': 'https://www.wikidata.org/wiki/Q424401', 'display_name': 'Epidermal growth factor receptor', 'level': 3, 'score': 0.63159674}, {'id': 'https://openalex.org/C42362537', 'wikidata': 'https://www.wikidata.org/wiki/Q87099740', 'display_name': 'Tyrosine kinase', 'level': 3, 'score': 0.6279358}, {'id': 'https://openalex.org/C2909325608', 'wikidata': 'https://www.wikidata.org/wiki/Q418369', 'display_name': 'Erlotinib Hydrochloride', 'level': 5, 'score': 0.5817264}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.5780016}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.55230486}, {'id': 'https://openalex.org/C2776362946', 'wikidata': 'https://www.wikidata.org/wiki/Q424374', 'display_name': 'Epidermal growth factor', 'level': 3, 'score': 0.50942403}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.46107864}, {'id': 'https://openalex.org/C130287650', 'wikidata': 'https://www.wikidata.org/wiki/Q17091190', 'display_name': 'Growth factor receptor inhibitor', 'level': 4, 'score': 0.44160247}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.38694984}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.36940837}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.36592633}, {'id': 'https://openalex.org/C170493617', 'wikidata': 'https://www.wikidata.org/wiki/Q208467', 'display_name': 'Receptor', 'level': 2, 'score': 0.3562979}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.26802516}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.21843418}], 'mesh': [{'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': True}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015153', 'descriptor_name': 'Blotting, Western', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002455', 'descriptor_name': 'Cell Division', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D045744', 'descriptor_name': 'Cell Line, Tumor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D002945', 'descriptor_name': 'Cisplatin', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D002945', 'descriptor_name': 'Cisplatin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019008', 'descriptor_name': 'Drug Resistance, Neoplasm', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D066246', 'descriptor_name': 'ErbB Receptors', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D000069347', 'descriptor_name': 'Erlotinib Hydrochloride', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008819', 'descriptor_name': 'Mice, Nude', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020928', 'descriptor_name': 'Mitogen-Activated Protein Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D020928', 'descriptor_name': 'Mitogen-Activated Protein Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D009369', 'descriptor_name': 'Neoplasms', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D047428', 'descriptor_name': 'Protein Kinase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017346', 'descriptor_name': 'Protein Serine-Threonine Kinases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D017346', 'descriptor_name': 'Protein Serine-Threonine Kinases', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D011518', 'descriptor_name': 'Proto-Oncogene Proteins', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D011518', 'descriptor_name': 'Proto-Oncogene Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051057', 'descriptor_name': 'Proto-Oncogene Proteins c-akt', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011799', 'descriptor_name': 'Quinazolines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D023041', 'descriptor_name': 'Xenograft Model Antitumor Assays', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1078-0432.ccr-04-0993', 'pdf_url': 'https://aacrjournals.org/clincancerres/article-pdf/11/4/1572/1961845/1572-1578.pdf', 'source': {'id': 'https://openalex.org/S183149254', 'display_name': 'Clinical Cancer Research', 'issn_l': '1078-0432', 'issn': ['1078-0432', '1557-3265'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15746062', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1158/1078-0432.ccr-04-0993', 'pdf_url': 'https://aacrjournals.org/clincancerres/article-pdf/11/4/1572/1961845/1572-1578.pdf', 'source': {'id': 'https://openalex.org/S183149254', 'display_name': 'Clinical Cancer Research', 'issn_l': '1078-0432', 'issn': ['1078-0432', '1557-3265'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.85, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 35, 'referenced_works': ['https://openalex.org/W1499694712', 'https://openalex.org/W1584899905', 'https://openalex.org/W1590794385', 'https://openalex.org/W1631165342', 'https://openalex.org/W1779286308', 'https://openalex.org/W1814699096', 'https://openalex.org/W1838340609', 'https://openalex.org/W1988174955', 'https://openalex.org/W2003418168', 'https://openalex.org/W2003719636', 'https://openalex.org/W2028561109', 'https://openalex.org/W2035998254', 'https://openalex.org/W2040239544', 'https://openalex.org/W2041456547', 'https://openalex.org/W2043696829', 'https://openalex.org/W2047083378', 'https://openalex.org/W2059048157', 'https://openalex.org/W2060433771', 'https://openalex.org/W2063210617', 'https://openalex.org/W2082721939', 'https://openalex.org/W2108929767', 'https://openalex.org/W2109823193', 'https://openalex.org/W2110835998', 'https://openalex.org/W2114918609', 'https://openalex.org/W2120718661', 'https://openalex.org/W2127101185', 'https://openalex.org/W2135836172', 'https://openalex.org/W2139658812', 'https://openalex.org/W2146404049', 'https://openalex.org/W2160610387', 'https://openalex.org/W2237040806', 'https://openalex.org/W2291334052', 'https://openalex.org/W2329407609', 'https://openalex.org/W2334507849', 'https://openalex.org/W2408236671'], 'related_works': ['https://openalex.org/W4381887247', 'https://openalex.org/W3106445303', 'https://openalex.org/W2968754080', 'https://openalex.org/W2801862162', 'https://openalex.org/W2750726335', 'https://openalex.org/W2619172668', 'https://openalex.org/W2150724094', 'https://openalex.org/W2141303400', 'https://openalex.org/W2119956903', 'https://openalex.org/W2014230197'], 'abstract_inverted_index': {'Abstract': [0], 'Purpose:': [1], 'Erlotinib': [2], '(Tarceva,': [3], 'OSI-774)': [4], 'is': [5, 205], 'a': [6], 'potent': [7], 'and': [8, 41, 44, 89, 117, 157], 'specific': [9], 'inhibitor': [10], 'of': [11, 50, 79, 86, 128, 224, 229], 'the': [12, 48, 68, 102, 131, 143, 163, 225], 'HER1/epidermal': [13], 'growth': [14], 'factor': [15], 'receptor': [16], '(EGFR)': [17], 'tyrosine': [18, 240], 'kinase.': [19], 'In': [20], 'phase': [21], 'II': [22], 'clinical': [23, 227], 'studies,': [24], 'oral': [25], 'erlotinib': [26, 80, 98, 129, 152, 186], 'monotherapy': [27], 'has': [28], 'shown': [29], 'antitumor': [30], 'activity': [31, 228], 'in': [32, 101, 130, 142, 202, 232], 'patients': [33, 233, 254], 'with': [34, 59, 154, 162, 176, 207, 215, 236, 255, 261], 'advanced': [35], 'non–small': [36], 'cell': [37, 92, 107, 114, 122, 133, 146, 166], 'lung': [38], 'cancer,': [39, 43], 'head': [40], 'neck': [42], 'ovarian': [45, 112], 'cancer': [46, 106], 'after': [47], 'failure': [49], 'standard': [51], 'chemotherapy.': [52], 'We': [53], 'hypothesized': [54], 'that': [55, 196, 257], 'some': [56, 203, 223], 'tumors': [57, 204, 256], 'treated': [58, 235, 260], 'multiple': [60, 237, 262], 'cytotoxic': [61, 171, 200], 'therapies': [62], 'may': [63, 221, 243], 'become': [64], 'more': [65, 245], 'dependent': [66], 'on': [67, 83], 'HER1/EGFR': [69, 156, 211, 217, 230, 239], 'signaling': [70], 'pathways': [71], 'for': [72, 252], 'survival.': [73], 'Experimental': [74], 'Design:': [75], 'The': [76, 125], 'growth-inhibitory': [77], 'effect': [78], 'was': [81, 99, 173], 'tested': [82], '10': [84], 'pairs': [85], 'chemosensitive,': [87], 'parental,': [88], 'chemoresistant': [90], 'tumor': [91], 'lines.': [93, 147, 167], 'Results:': [94], 'Enhanced': [95], 'sensitivity': [96, 150, 184, 209], 'to': [97, 137, 151, 170, 178, 185, 199, 210], 'observed': [100, 226], 'doxorubicin-resistant': [103], 'human': [104, 111, 119], 'breast': [105], 'line': [108, 115, 123], 'MCF-7,': [109], 'paclitaxel-resistant': [110], 'carcinoma': [113, 121], 'A2780,': [116], 'cisplatin-resistant': [118], 'cervical': [120], 'ME180.': [124], 'IC50': [126], 'values': [127], 'resistant': [132], 'lines': [134], 'were': [135, 258], '2-': [136], '20-fold': [138], 'lower': [139], 'than': [140, 187], 'those': [141], 'corresponding': [144, 164], 'parental': [145, 165, 188], 'This': [148], 'enhanced': [149, 208], 'correlated': [153], 'higher': [155], 'phospho-HER1/EGFR': [158], 'expression': [159], 'when': [160], 'compared': [161], 'Acquired': [168], 'resistance': [169, 198], 'agents': [172], 'not': [174], 'associated': [175, 206], 'cross-resistance': [177], 'erlotinib.': [179], 'AE-ME180/CDDP-resistant': [180], 'xenografts': [181, 190], 'showed': [182], 'greater': [183], 'ME180': [189], 'did.': [191], 'Conclusions:': [192], 'Our': [193], 'findings': [194], 'suggest': [195], 'acquired': [197], 'therapy': [201], 'inhibitors,': [212], 'which': [213], 'correlates': [214], 'increased': [216], 'expression.': [218], 'These': [219], 'data': [220], 'explain': [222], 'inhibitors': [231, 242], 'previously': [234, 259], 'therapies.': [238], 'kinase': [241], 'be': [244], 'effective': [246], 'as': [247], 'second-': [248], 'or': [249], 'third-line': [250], 'treatment': [251], 'certain': [253], 'chemotherapy': [263], 'regimens.': [264]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2020224707', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 4}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 3}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 4}, {'year': 2017, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 2}, {'year': 2015, 'cited_by_count': 2}, {'year': 2014, 'cited_by_count': 3}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 10}], 'updated_date': '2024-09-11T01:42:12.300989', 'created_date': '2016-06-24'}